Who funds tuberculosis research?
We count 136 funded tuberculosis projects, active between 2019 and 2033, from 6 funders. The most came from Wellcome (37 projects), Gates Foundation (36 projects) and EU · Health (21 projects). The median award is $2.7M, across the 128 of 136 projects that list an amount.
- Funded projects
- 136
- Funders
- 6
- Median award
- $2.7M
- Open calls now
- 0
Top funders of tuberculosis research
| Funder | Projects | Share | Median award |
|---|---|---|---|
| Wellcome | 37 | 27% | $3.7M |
| Gates Foundation | 36 | 26% | $1M |
| EU · Health | 21 | 15% | $4.3M |
| NIH · NIAID | 16 | 12% | $3.5M |
| EU · MSCA | 7 | 5% | $309K |
| EU · ERC | 6 | 4% | $2.6M |
| EU · Health, demographic change and well-being | 4 | 3% | $52.8M |
| UKRI · MRC | 3 | 2% | $928K |
| NIH · Office of the Director | 2 | 1% | — |
| EU · EIC | 1 | 1% | — |
Projects whose title or summary mentions tuberculosis. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.
Open tuberculosis funding calls
No open call mentions tuberculosis in our listings today. We add new calls twice a day; create a free account to get an alert when one opens.
Forecast: announced, not open yet
2 forecast calls on tuberculosis. Funders publish forecasts before a call opens; you can't apply to these yet, and dates can change.
-
ForecastStrengthening Collaboration Between Tuberculosis Control Programs and Affiliated Partners in the United States.
Centers for Disease Control - NCHHSTPNot specifiedExpected to open March 22, 2027
-
ForecastImproved Drug Susceptibility Testing (DST) for Mycobacteria
National Institutes of HealthNot specifiedExpected to open March 12, 2027
Funded tuberculosis projects
A sample, latest start first, at most three per program.
-
Antibiotic efficacy in the tuberculosis cellular environments
Wellcome · £3,399,800 · ends 2033
-
Clonal and functional T cell determinants of protection and pathogenesis in tuberculosis.
Wellcome · £3,745,466 · ends 2033
-
Phase 3 trial to assess M72/AS01E-4 Mycobacterium tuberculosis (TB) vaccine
Wellcome · £125,955,160 · ends 2033
-
Facilitating Accelerated Science and Translation for TB Regimen Development (FAST-TB)
NIH · NIAID · $3,499,366 · ends 2031
-
Microbiology of Treatment Shortening in Tuberculosis"
NIH · NIAID · $3,589,323 · ends 2031
-
Accelerator for the rapid development of countermeasures targeting drug resistant fungal pathogens
NIH · NIAID · $6,977,446 · ends 2030
-
Stellenbosch University — Tuberculosis
Gates Foundation · $3,315,335 · ends 2030
-
Rehabilitation with embedded mental health and diabetes services to address multiple long-term conditions among people with tuberculosis (RESTORE)
UKRI · MRC · £1,417,616 · ends 2030
-
Colorado State University — Tuberculosis
Gates Foundation · $3,995,398 · ends 2029
-
Liverpool School of Tropical Medicine — Tuberculosis
Gates Foundation · $4,950,000 · ends 2029
How we count
Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “tuberculosis”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.
Get matched with tuberculosis calls that fit your research
Build a free research profile and Lantern Grants scores every open call against your work, tracks your deadlines and reminds you before they pass.
Get matched free